Palvella Wins PACT Award Amid Rare Disease Drug Push
WAYNE, PA — Palvella Therapeutics (Nasdaq: PVLA) received the 2026 Healthcare & Life Sciences Company of the Year award from the Philadelphia Alliance for Capital and Technologies as the clinical-stage …
Palvella Wins PACT Award Amid Rare Disease Drug Push Read More